Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Hengrui's Class 1 New Drug Fluzoparib has been Applied for New Clinical Trials

PharmaSources/CaicaiFebruary 03, 2020

Tag: Sun Piaoyang , Hengrui , Fluzoparib

PharmaSources Customer Service